C4 Therapeutics Statistics
Total Valuation
CCCC has a market cap or net worth of $279.53 million. The enterprise value is $68.58 million.
Important Dates
The last earnings date was Thursday, October 31, 2024, before market open.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CCCC has 70.59 million shares outstanding. The number of shares has increased by 31.51% in one year.
Current Share Class | 70.59M |
Shares Outstanding | 70.59M |
Shares Change (YoY) | +31.51% |
Shares Change (QoQ) | +1.19% |
Owned by Insiders (%) | 2.65% |
Owned by Institutions (%) | 72.31% |
Float | 47.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.76 |
Forward PS | n/a |
PB Ratio | 1.18 |
P/TBV Ratio | 1.18 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.04 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.28.
Current Ratio | 6.31 |
Quick Ratio | 6.14 |
Debt / Equity | 0.28 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.00% and return on invested capital (ROIC) is -24.44%.
Return on Equity (ROE) | -46.00% |
Return on Assets (ROA) | -20.61% |
Return on Capital (ROIC) | -24.44% |
Revenue Per Employee | $232,193 |
Profits Per Employee | -$727,566 |
Employee Count | 145 |
Asset Turnover | 0.09 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CCCC has paid $277,000 in taxes.
Income Tax | 277,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +123.76% in the last 52 weeks. The beta is 3.06, so CCCC's price volatility has been higher than the market average.
Beta (5Y) | 3.06 |
52-Week Price Change | +123.76% |
50-Day Moving Average | 5.77 |
200-Day Moving Average | 6.43 |
Relative Strength Index (RSI) | 27.82 |
Average Volume (20 Days) | 1,001,800 |
Short Selling Information
The latest short interest is 5.85 million, so 8.29% of the outstanding shares have been sold short.
Short Interest | 5.85M |
Short Previous Month | 6.65M |
Short % of Shares Out | 8.29% |
Short % of Float | 12.38% |
Short Ratio (days to cover) | 8.83 |
Income Statement
In the last 12 months, CCCC had revenue of $33.67 million and -$105.50 million in losses. Loss per share was -$1.63.
Revenue | 33.67M |
Gross Profit | -74.85M |
Operating Income | -116.90M |
Pretax Income | -106.59M |
Net Income | -105.50M |
EBITDA | -115.13M |
EBIT | -116.90M |
Loss Per Share | -$1.63 |
Full Income Statement Balance Sheet
The company has $255.64 million in cash and $67.10 million in debt, giving a net cash position of $217.31 million or $3.08 per share.
Cash & Cash Equivalents | 255.64M |
Total Debt | 67.10M |
Net Cash | 217.31M |
Net Cash Per Share | $3.08 |
Equity (Book Value) | 242.66M |
Book Value Per Share | 3.44 |
Working Capital | 229.94M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$71.23 million and capital expenditures -$341,000, giving a free cash flow of -$71.58 million.
Operating Cash Flow | -71.23M |
Capital Expenditures | -341,000 |
Free Cash Flow | -71.58M |
FCF Per Share | -$1.01 |
Full Cash Flow Statement Margins
Gross Margin | -222.31% |
Operating Margin | -347.20% |
Pretax Margin | -312.52% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -268.10% |
Dividends & Yields
CCCC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -31.51% |
Shareholder Yield | -31.51% |
Earnings Yield | -36.90% |
FCF Yield | -25.04% |
Analyst Forecast
The average price target for CCCC is $10.00, which is 152.53% higher than the current price. The consensus rating is "Buy".
Price Target | $10.00 |
Price Target Difference | 152.53% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 176.06% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CCCC has an Altman Z-Score of -0.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.8 |
Piotroski F-Score | 3 |